Blog
Practical Kidney Education Built for You

I know that this title may seem misleading given my positive stance on GLP-1s. However, it highlights a significant issue with periodicals and their tendency to use clickbait titles. Unfortunately, you often only discover the author's true message after reading through half the article. This can lead to misunderstandings about the importance of these groundbreaking medications. Titles like these can also fuel rumors that patients should stop using these medications when they

A summary and commentary on: Čižman B, Butler EL, Stavas J, et al. A Randomized Clinical Trial of Kidney Autologous Cell Therapy in Diabetic Kidney Disease. Clin J Am Soc Nephrol. Published January 2, 2026. doi:10.2215/CJN.0000000969 So if you have not heard, there has been some excitement in the world of kidney disease lately! An article came out in January 2026 discussing a possible and promising use of stem cell therapy to address diabetic kidney disease. Why Are We Excite

An updated version from the last post Andrew Kowalski, MD, FASN CKD remains one of the most underdiagnosed and undertreated conditions in modern medicine, affecting more than one in ten adults worldwide and dramatically increasing the risk of cardiovascular disease, kidney failure, and premature death . For decades, our therapeutic approach rested on a familiar foundation, The Big 4: Blood pressure control Renin-angiotensin system blockade Glycemic management in those with d

Andrew Kowalski, MD, FASN Chronic Kidney Disease (CKD) is a serious health condition affecting millions of people worldwide,...

Andrew Kowalski, MD, FASN In recent years, there has been a growing interest in the relationship between GLP-1 receptor agonists and...